MyFinsight
Home
Blog
About
Back
Income Statement
Cadrenal Therapeutics, Inc. (CVKD)
Cadrenal Therapeutics, Inc. (CVKD)
source: myfinsight.com
Interest and dividend
income
$17,835
(-73.38%↓ Y/Y)
Net loss and
comprehensive loss
-$3,322,565
(9.40%↑ Y/Y)
Total other income
$17,835
(-73.38%↓ Y/Y)
Loss from operations
-$3,340,400
(10.55%↑ Y/Y)
Total operating
expenses
$3,340,400
(-10.55%↓ Y/Y)
General and
administrative expenses
$2,634,745
(-0.81%↓ Y/Y)
Research and development
expenses
$705,151
(-34.56%↓ Y/Y)
Depreciation expense
$504
(25.69%↑ Y/Y)
Back